← Back to Patent Explorer
US4213995A Expired / Lapsed US ⏱️ 0.0 years remaining

2-Phenylimino-imidazolidines and salts thereof

Assignee: Boehringer Ingelheim GmbH
•
Filing: 1979-02-12
•
Granted: 1980-07-22
•
Expires: 1999-02-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula <IMAGE> wherein R is 2,6-dichloro-4-hydroxymethyl-phenyl; 2-chloro-4-methyl-5-amino-phenyl; 2,5-dichloro-4-methyl-phenyl; 2-chloro-4-methyl-5-nitro-phenyl; 2,3-dichloro-4-methyl-phenyl; 2-chloro-4-methyl-6-nitro-phenyl; 2-chloro-4-methyl-6-amino-phenyl; 2,4,6-trifluorophenyl; tetrafluoro-phenyl; or 3-bromo-4-fluoro-phenyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as hypotensives.

Inventors

  • 👤 Helmut Stahle
  • 👤 Herbert Koppe
  • 👤 Werner Kummer
  • 👤 Wolfgang Hoefke
  • 👤 Ludwig Pichler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 13:35
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/04; C07D233/28; C07D233/44; C07D233/50; A; A61; A61P; A61P9/00

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 21 words
A compound of the formula ##STR5## wherein R is 2,6-dichloro-4-hydroxymethyl-phenyl or tetrafluoro-phenyl; or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 21 words
A compound of the formula ##STR5## wherein R is 2,6-dichloro-4-hydroxymethyl-phenyl or tetrafluoro-phenyl; or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 24 words
A hypotensive pharmaceutical dosage unit composition consisting essentially of an inert pharmaceutical carrier and an effective hypotensive amount of a compound of claim 1.
Claim 4
Dependent Claim 33 words
The method of reducing the blood pressure of a warm-blooded animal in need thereof, which comprises enterally or parenterally administering to said animal an effective hypotensive amount of a compound of claim 1.

References Cited (Backward Citations)

BE623305A Cited
US3236857A Cited
BE653933A Cited
BE687657A Cited
BE687656A Cited
FR1506408A Cited
US3595961A Cited
BE705944A Cited
US3468887A Cited
DE2356005A1 Cited
US4025607A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-07-22 1984-01-21 1984-07-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-07-22 1988-01-21 1988-07-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-07-22 1992-01-21 1992-07-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag